Articles by : Bella Czajkowski, National Correspondent

State Contract Pharmacy Lawsuit Roundup: Health Center Group Motion Denied in 5th Circuit; Drug Industry Makes Motion in Federal Court in South Dakota

May 30, 2025 Bella Czajkowski, National Correspondent Views

Key briefs were filed in litigation on contract pharmacy access laws in Louisiana and South Dakota.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Novo Nordisk, Merck, GSK to Refund 340B Covered Entities for Overcharges

May 30, 2025 Bella Czajkowski, National Correspondent Views

Novo Nordisk, Merck and GSK announced they will refund covered entities following certain overcharges for 340B drugs.

Three drugmakers will refund covered entities that purchased certain 340B-priced medications following recent adjustments to their 340B drug ceiling prices. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

House GOP Lawmaker Spartz Introduces Bill That 340B Provider Advocates Say Would Drive Them Out of the Program and Potentially Force Closures

May 28, 2025 Bella Czajkowski, National Correspondent Views

U.S. Rep. Victoria Spartz (R-Ind.) introduced the legislation (H.R. 3222), known as the “Stopping Medicare Abuses to Restore Trust in Health Care Act” or SMART Health Care Act, on May 6. 340B provider advocates strongly oppose the bill's 340B provisions.

An Indiana congresswoman recently introduced a controversial U.S. House bill that could potentially require 340B covered entities to pass all [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Roundup: Key Briefs in 8th Circuit, Utah, South Dakota; Motion Filed in 5th Circuit

May 22, 2025 Bella Czajkowski, National Correspondent Views

Key briefs and motions were filed recently in the 8th Circuit and 5th Circuit Appeals Courts, as well as federal district courts in Utah and South Dakota.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Viatris, Amgen, GSK Announce 340B Refunds; Amgen Issues NDC Change

May 20, 2025 Bella Czajkowski, National Correspondent Views

Viatris and two other drugmakers recently issued notices to 340B covered entities.

Three drugmakers recently announced refunds for 340B covered entities that were overcharged when buying certain drugs. Viatris, Amgen and GSK [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Hospital, Pharmacist Advocates File Brief Backing Nebraska’s New 340B Contract Pharmacy Access Law Against AbbVie Challenge

May 15, 2025 Bella Czajkowski, National Correspondent Views

Hospital and pharmacist advocacy groups argued that a federal district court should uphold Nebraska's contract pharmacy access law.

Multiple hospital advocacy groups have filed an amicus brief urging a federal district judge to uphold Nebraska’s recently enacted 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AbbVie, Sobi, Organon Exempt More States from 340B Contract Pharmacy Restrictions

May 15, 2025 Bella Czajkowski, National Correspondent Views

Organon is one of three drugmakers to recently announce new state-level exemptions to its 340B contract pharmacy restrictions.

Three drugmakers recently announced they will exempt additional states from their 340B contract pharmacy restrictions in light of new contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drug Industry-Funded White Paper Ties 340B to Rising Commercial Insurance Premiums; Provider Advocates Criticize Study

May 15, 2025 Bella Czajkowski, National Correspondent Views

A recent drug industry-funded white paper drew a connection between 340B and increases in commercial insurance premiums, but provider advocates and attorneys criticized its methodology and findings.

The 340B program is driving up employer-sponsored health insurance premiums, according to a drug industry-funded white paper. Provider advocates criticized [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

In Novel Approach, Vertex to Automatically Exempt States from 340B Contract Pharmacy Restrictions as New Laws Take Effect and Apply Exemptions Liberally; Other Companies Exempt Additional States

May 8, 2025 Bella Czajkowski, National Correspondent Views

Multiple drugmakers announced exemptions to contract pharmacy restrictions recently, including Vertex, which will automatically exempt states that enact contract pharmacy access laws moving forward.

Four drugmakers recently announced they will exempt additional states from their 340B contract pharmacy restrictions in response to a flurry [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Contract Pharmacy Lawsuit Roundup: Key Briefs Filed in Nebraska, South Dakota and 5th Circuit

May 8, 2025 Bella Czajkowski, National Correspondent Views

Key briefs were filed recently in Nebraska, South Dakota and the 5th Circuit.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live